Antares Vision Group played a role in the latest phase of an ongoing study by Michigan State University’s The Axia Institute that tests the feasibility of applying RFID technology to streamline pharma traceability throughout the supply chain.
Neil Smith, CPG president, Schneider Electric comments on the importance of the upcoming UK Point of Care manufacturing legislation that came into force today (23rd July 2025).
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
Neuraxpharm announces the launch of a new affiliate, Neuraxpharm Australia, led by newly appointed head of commercial, Avendran Naidu, as the Company continues to expand globally.
Vicebio, a biopharmaceutical company developing vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi.
Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.
Logical Biological, biospecimen and critical material experts, has announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing.
Aenova, a global contract development and manufacturing organisation (CDMO), is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders.
Meech International has introduced the 906 Hyperion 24V Power Supply Unit (PSU), a compact, high-voltage AC power supply with 24VDC input developed to support static management equipment across a wide range of industrial settings.
As the UK’s transition away from F-gases ramps up, Aggreko has published a new report to provide clarity on the latest regulations and offer businesses guidance on the phase-down.